RecruitingACTRN12621001649808
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In CamberwellSchizophreniaInterventional studyAges 18–55
- Countries
- Australia
- Sponsor
- Monash University
RecruitingNCT07263022
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In MinneapolisSchizophrenia, Depression, ...Medication studyAges 18–35
- Countries
- United States
- Sponsor
- University of Minnesota
RecruitingNCT07455929
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In BerlinSchizophreniaBehavioural studyAges 18–65
- Countries
- Germany
- Sponsor
- Charite University, Berlin, Germany
RecruitingNCT07265180
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In BerlinSchizophreniaPlacebo comparisonAges 18–75
- Countries
- Germany
- Sponsor
- Charite University, Berlin, Germany
RecruitingNCT06608706
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
Multiple locations, including BergenSchizophreniaInterventional studyAges 16+
- Countries
- Norway
- Sponsor
- Haukeland University Hospital
RecruitingNCT07290738
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In HoustonSchizophreniaDevice studyAges 18–60
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
Not Yet RecruitingNCT07342465
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
This study isn't recruiting yet.
In CambridgeSchizophreniaDevice studyAges 18–65
- Countries
- United States
- Sponsor
- Massachusetts Institute of Technology
Not Yet RecruitingNCT07152184
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
This study isn't recruiting yet.
Location not clearly listedSchizophreniaMedication studyAges 18–60
- Countries
- Sponsor
- University Hospital, Strasbourg, France
RecruitingNCT01392885
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In VancouverSchizophreniaObservational studyAges 19–45
- Countries
- Canada
- Sponsor
- BC Mental Health and Addictions Research Institute
RecruitingNCT07010614
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In StanfordSchizophreniaDevice studyAges 18–65
- Countries
- United States
- Sponsor
- Stanford University
RecruitingNCT05208190
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
Multiple locations, including Los AngelesSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
RecruitingNCT06745479
What is this study about?A short description of this study's objective has not yet been verified by HopeStage.
In PiscatawaySchizophreniaBehavioural studyAges 18–50
- Countries
- United States
- Sponsor
- Rutgers, The State University of New Jersey
Data coveragePublic registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
Get research updates
